A theme the specialists are building · as of 2026-10-26
Rare Disease Innovation
This basket is a high-beta biotech expression around clinical readouts, financing access, and regulatory value creation in rare and specialty disease programs.
6 proven specialist funds in5 stocks in the basket1 Consensus3 Tracked1 Unknown
EDITConsensusCRISPR therapies for inherited genetic diseases: one name revealed, on us
The other 4 names, each with its role and stage, are inside.See the basket with a free account →
Themes are read from quarterly filings of proven specialist funds plus the options tape. Evidence, not advice. Track our public record on The Book.